Th9 Cells: Probable players in ulcerative colitis pathogenesis

T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of diff...

Full description

Saved in:
Bibliographic Details
Published inInternational reviews of immunology Vol. 37; no. 4; pp. 192 - 205
Main Authors Shohan, Mojtaba, Elahi, Shokrollah, Shirzad, Hedayatollah, Rafieian-Kopaei, Mahmoud, Bagheri, Nader, Soltani, Emad
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 04.07.2018
Subjects
Online AccessGet full text
ISSN0883-0185
1563-5244
1563-5244
DOI10.1080/08830185.2018.1457659

Cover

Loading…
Abstract T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field.
AbstractList T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field.
T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field.T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most important activator cells in inflammatory conditions. Depending on the type of induced cells and inflamed sites, expression and activity of different subtypes of helper T cells are changed. Recent studies have confirmed the existence of a new subset of helper T lymphocytes called Th9. Naive T cells can differentiate into Th9 subtypes if they are exposed simultaneously by interleukin (IL) 4 and transforming growth factor β and also secondary activation of a complicated network of transcription factors such as interferon regulatory factor 4 (IRF4) and Smads which are essential for adequate induction of this phenotype. Th9 cells specifically produce interleukin 9 and their probable roles in promoting intestinal inflammation are being investigated in human subjects and experimental models of ulcerative colitis (UC). Recently, infiltration of Th9 cells, overexpression of IL-9, and certain genes associated with Th9 differentiation have been demonstrated in inflammatory microenvironment of UC. Intestinal oversecretion of IL-9 protein is likely to break down epithelial barriers and compromise tolerance to certain commensal microorganisms which leads to inflammation. Th9 pathogenicity has not yet been adequately explored in UC and they are far from being considered as inflammatory cells in this milieu, therefore precise understanding the role of these newly identified cells in particular their potential role in gut pathogenesis may enable us to develop novel therapeutic approaches for inflammatory bowel disease. So, this article tries to discuss the latest knowledge on the above-mentioned field.
Author Shohan, Mojtaba
Elahi, Shokrollah
Rafieian-Kopaei, Mahmoud
Bagheri, Nader
Soltani, Emad
Shirzad, Hedayatollah
Author_xml – sequence: 1
  givenname: Mojtaba
  surname: Shohan
  fullname: Shohan, Mojtaba
  organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences
– sequence: 2
  givenname: Shokrollah
  surname: Elahi
  fullname: Elahi, Shokrollah
  organization: Department of Dentistry, Department of Medical Microbiology and Immunology, Faculty of Medicine and Dentistry, University of Alberta
– sequence: 3
  givenname: Hedayatollah
  surname: Shirzad
  fullname: Shirzad, Hedayatollah
  email: shirzad1951@yahoo.com
  organization: Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences
– sequence: 4
  givenname: Mahmoud
  orcidid: 0000-0003-3190-7863
  surname: Rafieian-Kopaei
  fullname: Rafieian-Kopaei, Mahmoud
  organization: Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences
– sequence: 5
  givenname: Nader
  surname: Bagheri
  fullname: Bagheri, Nader
  organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences
– sequence: 6
  givenname: Emad
  surname: Soltani
  fullname: Soltani, Emad
  organization: Department of Microbiology and Immunology, Faculty of Medicine, Shahrekord University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29672174$$D View this record in MEDLINE/PubMed
BookMark eNqFkDFv2zAQhYkiRWKn-QktNGaRe6RIimyAIIXRJAUMtIM7ExR1ihnQokPKLfzvK8P2kiFZ7pbvvbv3puSsjz0S8pnCjIKCr6BUBVSJGRvnjHJRS6E_kAkVsioF4_yMTPZMuYcuyDTnZwBaCc3PyQXTsma05hNyu1zpYo4h5G_F7xQb2wQsNsHuMOXC98U2OEx28H-xcDH4wediY4dVfMIes8-fyMfOhoxXx31J_tz_WM4fy8Wvh5_z74vSVVIOZdVS0TgAB12jnHICZNMKqcBRK2stkTUWaqdbDg4VKMe7VmMHDfKOs4pVl-T64LtJ8WWLeTBrn934tu0xbrNhwJTmmjM1ol-O6LZZY2s2ya9t2plT5hG4OQAuxZwTdsb5YYwY-yFZHwwFs2_YnBo2-4bNseFRLV6pTwfe090ddL7vYlrbfzGF1gx2F2Lqku2dz6Z62-I_sBuRJw
CitedBy_id crossref_primary_10_1007_s11726_024_1424_6
crossref_primary_10_1016_j_jaci_2024_11_031
crossref_primary_10_1097_JCMA_0000000000000202
crossref_primary_10_1111_sji_13412
crossref_primary_10_1016_j_intimp_2024_112486
crossref_primary_10_1007_s43440_020_00213_z
crossref_primary_10_3389_fphar_2022_1070184
crossref_primary_10_3390_ijms20081912
crossref_primary_10_3390_jcm11020400
crossref_primary_10_3390_ijms24032696
crossref_primary_10_1155_2020_6503539
crossref_primary_10_1080_08830185_2018_1499488
crossref_primary_10_1128_IAI_00014_21
crossref_primary_10_1002_iub_2295
Cites_doi 10.1111/imr.12028
10.1078/0065-1281-00641
10.1038/ni.2390
10.1038/mi.2012.77
10.1016/j.immuni.2010.07.014
10.1016/j.cell.2006.02.017
10.4049/jimmunol.164.11.5549
10.1038/mi.2015.59
10.1002/eji.200939618
10.1016/j.immuni.2014.10.004
10.1016/S1074-7613(00)80439-2
10.4049/jimmunol.1000356
10.1016/j.immuni.2016.05.009
10.3389/fimmu.2016.00409
10.1158/1078-0432.CCR-05-1426
10.1074/jbc.M206473200
10.1038/ni.2303
10.1038/ni.1802
10.1084/jem.20090246
10.3748/wjg.v13.i22.3027
10.1016/j.it.2011.01.006
10.1371/journal.pone.0115195
10.1182/blood-2008-05-078154
10.1016/S0091-6749(99)70165-X
10.1038/ni.1659
10.4049/jimmunol.1200808
10.1111/j.1365-2567.2010.03332.x
10.1164/rccm.201211-2073OC
10.1016/j.bbrc.2015.11.057
10.1038/ncomms5575
10.1053/j.gastro.2006.04.020
10.4161/21688370.2014.983777
10.4049/jimmunol.1000986
10.1016/j.jneuroim.2010.06.002
10.1146/annurev-immunol-032713-120218
10.1371/journal.ppat.1003913
10.1016/j.micpath.2015.03.010
10.1155/2012/925135
10.1016/S0091-6749(00)90185-4
10.1016/j.coi.2012.01.014
10.1038/nature05010
10.1016/S0140-6736(07)60750-8
10.1016/j.micpath.2015.01.008
10.1016/j.arcmed.2016.07.013
10.1111/j.1582-4934.2001.tb00169.x
10.1016/j.jaci.2015.01.021
10.1152/ajpgi.00513.2005
10.1002/ibd.21709
10.1007/s11481-009-9186-y
10.4049/jimmunol.164.8.4197
10.1016/j.immuni.2012.08.024
10.1016/j.autrev.2016.02.020
10.1038/icb.2010.53
10.4049/jimmunol.0900085
10.1073/pnas.1006451107
10.5812/jjm.21701
10.1172/JCI69489
10.1038/ni.2920
10.1007/s00281-016-0600-2
10.1038/nri3299
10.1093/intimm/dxt039
10.1136/gut.2008.163667
10.1093/intimm/dxw006
10.1136/gut.2007.135053
10.1016/j.immuni.2013.07.020
10.1016/j.biocel.2012.05.003
10.1016/j.immuni.2011.07.010
10.1016/j.immuni.2013.01.007
10.1016/j.jaci.2009.09.054
10.4049/jimmunol.0901471
10.1111/cea.12787
10.4049/jimmunol.178.5.3244
10.1165/ajrcmb.19.5.3457
10.1126/science.1219328
10.1016/j.jaci.2013.09.049
10.1155/2014/781649
10.1111/j.1749-6632.2011.06351.x
10.1016/j.cytogfr.2017.07.004
10.1016/j.micpath.2013.12.006
10.1038/nrgastro.2014.201
10.1126/science.1198469
10.1038/nri2653
10.3892/mmr.2013.1258
10.1172/JCI65459
10.1007/s12026-014-8540-1
10.1016/j.cell.2011.09.025
10.1016/j.it.2013.10.004
10.1007/s00281-016-0611-z
10.4049/jimmunol.166.7.4391
10.1073/pnas.0812530106
10.1111/j.1365-2567.2012.03612.x
10.1016/j.cyto.2015.10.008
10.1136/gutjnl-2013-305947
10.1016/j.immuni.2012.01.020
10.1002/eji.201242825
10.1074/jbc.274.36.25855
10.1016/j.jaci.2005.03.011
10.1002/ibd.21248
10.4049/jimmunol.165.4.1847
10.1164/rccm.2105079
10.1038/nature11225
10.1016/j.cytogfr.2013.09.001
10.1128/MCB.16.9.4710
10.4049/jimmunol.0900363
10.1038/nature07674
10.1038/ni1500
10.1016/j.jaci.2016.01.055
10.1007/BF00204898
10.1155/2015/895416
10.1016/j.ajpath.2012.03.044
10.4049/jimmunol.174.6.3237
10.1074/jbc.273.15.9255
10.1016/j.immuni.2015.08.020
10.1016/j.cytogfr.2016.02.002
10.1111/imr.12634
10.1016/j.cyto.2004.01.006
10.1038/ni.1867
10.4049/jimmunol.0801941
10.1164/ajrccm.153.4.8616554
10.1016/j.coi.2012.02.001
10.1016/S0171-2985(11)80414-6
10.1038/s41598-017-02422-8
10.4049/jimmunol.1303184
10.3109/08820139.2015.1122615
10.4049/jimmunol.1203420
10.1007/s00281-016-0606-9
10.4049/jimmunol.1003049
10.1038/s41467-017-00674-6
10.4049/jimmunol.1301276
10.1073/pnas.0809077106
10.1165/rcmb.2002-0207OC
10.1073/pnas.1301138111
10.1038/nri2848
10.4049/jimmunol.1502383
10.1186/1465-9921-6-33
10.1002/eji.201646846
10.4049/jimmunol.0901906
10.1136/gutjnl-2012-303955
10.1111/j.1365-3083.2010.02432.x
10.1038/sj.ejhg.5200541
10.1038/nri2785
10.1002/cyto.a.22348
10.1067/mai.2003.1485
10.1038/ni.3489
10.1016/j.meegid.2018.02.020
10.1016/j.micpath.2017.06.040
10.1007/978-94-017-9487-9_8
ContentType Journal Article
Copyright 2018 Taylor & Francis 2018
Copyright_xml – notice: 2018 Taylor & Francis 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/08830185.2018.1457659
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1563-5244
EndPage 205
ExternalDocumentID 29672174
10_1080_08830185_2018_1457659
1457659
Genre Review
Journal Article
GroupedDBID ---
00X
03L
0BK
0R~
29J
36B
4.4
53G
5GY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFW
TUROJ
TUS
UEQFS
UHWXJ
V1S
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
0VX
5VS
AALIY
AAORF
ABWCV
ABZEW
ACKZS
ACOPL
ADFOM
ADFZZ
AEIIZ
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
JENTW
LJTGL
M44
NPM
NUSFT
QQXMO
7X8
TASJS
ID FETCH-LOGICAL-c366t-3d15bc00c0fb8c8c506bd5680c1a6796e2ba07c9d40ce808c4fd9ef0be4f42323
ISSN 0883-0185
1563-5244
IngestDate Fri Sep 05 05:58:52 EDT 2025
Thu Apr 03 07:06:43 EDT 2025
Thu Apr 24 22:56:34 EDT 2025
Tue Jul 01 00:24:17 EDT 2025
Wed Dec 25 09:08:52 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Intestinal inflammation
ulcerative colitis
Th9
IL-9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-3d15bc00c0fb8c8c506bd5680c1a6796e2ba07c9d40ce808c4fd9ef0be4f42323
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3190-7863
PMID 29672174
PQID 2028949428
PQPubID 23479
PageCount 14
ParticipantIDs pubmed_primary_29672174
crossref_citationtrail_10_1080_08830185_2018_1457659
informaworld_taylorfrancis_310_1080_08830185_2018_1457659
proquest_miscellaneous_2028949428
crossref_primary_10_1080_08830185_2018_1457659
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-07-04
PublicationDateYYYYMMDD 2018-07-04
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-04
  day: 04
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle International reviews of immunology
PublicationTitleAlternate Int Rev Immunol
PublicationYear 2018
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References cit0077
cit0110
cit0078
cit0111
cit0075
cit0076
cit0073
cit0074
cit0071
cit0072
cit0070
cit0118
cit0119
cit0116
cit0117
cit0114
cit0115
cit0079
cit0112
cit0113
cit0066
cit0067
cit0100
cit0064
cit0065
cit0062
cit0063
cit0060
cit0061
cit0109
cit0107
cit0108
Zundler S (cit0155) 2016
cit0105
cit0106
cit0103
cit0104
cit0068
cit0101
cit0069
cit0102
cit0011
cit0099
cit0132
cit0012
cit0133
cit0097
cit0130
cit0010
cit0098
cit0131
cit0095
cit0096
cit0093
Shirzad H (cit0144) 2015; 78
cit0094
cit0091
cit0092
cit0090
cit0019
cit0017
cit0138
cit0018
cit0139
cit0015
cit0136
cit0016
cit0013
cit0134
cit0014
cit0135
cit0088
cit0121
cit0001
cit0089
cit0122
cit0086
cit0087
cit0120
cit0084
cit0085
cit0082
cit0083
cit0080
cit0081
cit0008
cit0129
cit0009
cit0006
cit0127
cit0007
cit0128
cit0004
cit0125
cit0005
cit0126
cit0002
cit0123
cit0003
cit0124
cit0033
cit0154
cit0034
cit0031
cit0152
cit0032
cit0153
cit0150
cit0030
cit0151
cit0039
cit0037
cit0038
cit0035
cit0036
cit0022
cit0143
cit0023
cit0020
cit0141
cit0021
cit0142
cit0140
cit0028
cit0149
cit0029
cit0026
cit0147
cit0027
cit0148
cit0024
cit0145
cit0025
cit0146
cit0055
cit0056
cit0053
cit0054
Silverberg MS (cit0137) 2005; 19
cit0051
cit0052
cit0050
cit0059
cit0057
cit0058
cit0044
cit0045
cit0042
cit0043
cit0040
cit0041
cit0048
cit0049
cit0046
cit0047
References_xml – ident: cit0033
  doi: 10.1111/imr.12028
– ident: cit0053
  doi: 10.1078/0065-1281-00641
– ident: cit0096
  doi: 10.1038/ni.2390
– ident: cit0135
  doi: 10.1038/mi.2012.77
– ident: cit0067
  doi: 10.1016/j.immuni.2010.07.014
– ident: cit0121
  doi: 10.1016/j.cell.2006.02.017
– ident: cit0050
  doi: 10.4049/jimmunol.164.11.5549
– ident: cit0058
  doi: 10.1038/mi.2015.59
– ident: cit0061
  doi: 10.1002/eji.200939618
– ident: cit0020
  doi: 10.1016/j.immuni.2014.10.004
– ident: cit0060
  doi: 10.1016/S1074-7613(00)80439-2
– ident: cit0043
  doi: 10.4049/jimmunol.1000356
– ident: cit0083
  doi: 10.1016/j.immuni.2016.05.009
– ident: cit0118
  doi: 10.3389/fimmu.2016.00409
– ident: cit0056
  doi: 10.1158/1078-0432.CCR-05-1426
– ident: cit0131
  doi: 10.1074/jbc.M206473200
– ident: cit0059
  doi: 10.1038/ni.2303
– ident: cit0014
  doi: 10.1038/ni.1802
– ident: cit0037
  doi: 10.1084/jem.20090246
– ident: cit0052
  doi: 10.3748/wjg.v13.i22.3027
– ident: cit0066
  doi: 10.1016/j.it.2011.01.006
– ident: cit0116
  doi: 10.1371/journal.pone.0115195
– ident: cit0001
  doi: 10.1182/blood-2008-05-078154
– ident: cit0092
  doi: 10.1016/S0091-6749(99)70165-X
– ident: cit0031
  doi: 10.1038/ni.1659
– ident: cit0086
  doi: 10.4049/jimmunol.1200808
– ident: cit0106
  doi: 10.1111/j.1365-2567.2010.03332.x
– ident: cit0087
  doi: 10.1164/rccm.201211-2073OC
– ident: cit0139
  doi: 10.1016/j.bbrc.2015.11.057
– ident: cit0076
  doi: 10.1038/ncomms5575
– ident: cit0130
  doi: 10.1053/j.gastro.2006.04.020
– ident: cit0005
  doi: 10.4161/21688370.2014.983777
– ident: cit0082
  doi: 10.1038/ncomms5575
– ident: cit0040
  doi: 10.4049/jimmunol.1000986
– ident: cit0042
  doi: 10.1016/j.jneuroim.2010.06.002
– ident: cit0104
  doi: 10.1146/annurev-immunol-032713-120218
– ident: cit0103
  doi: 10.1371/journal.ppat.1003913
– ident: cit0146
  doi: 10.1016/j.micpath.2015.03.010
– ident: cit0002
  doi: 10.1155/2012/925135
– ident: cit0100
  doi: 10.1016/S0091-6749(00)90185-4
– ident: cit0011
  doi: 10.1016/j.coi.2012.01.014
– ident: cit0044
  doi: 10.1038/nature05010
– ident: cit0136
  doi: 10.1016/S0140-6736(07)60750-8
– ident: cit0142
  doi: 10.1016/j.micpath.2015.01.008
– ident: cit0143
  doi: 10.1016/j.arcmed.2016.07.013
– ident: cit0129
  doi: 10.1111/j.1582-4934.2001.tb00169.x
– ident: cit0048
  doi: 10.1016/j.jaci.2015.01.021
– ident: cit0151
  doi: 10.1152/ajpgi.00513.2005
– ident: cit0123
  doi: 10.1002/ibd.21709
– ident: cit0025
  doi: 10.1038/ni.2303
– ident: cit0152
  doi: 10.1007/s11481-009-9186-y
– ident: cit0110
  doi: 10.4049/jimmunol.164.8.4197
– ident: cit0012
  doi: 10.1016/j.immuni.2012.08.024
– ident: cit0021
  doi: 10.1016/j.autrev.2016.02.020
– ident: cit0078
  doi: 10.1038/icb.2010.53
– ident: cit0109
  doi: 10.4049/jimmunol.0900085
– ident: cit0128
  doi: 10.1073/pnas.1006451107
– ident: cit0148
  doi: 10.5812/jjm.21701
– ident: cit0079
  doi: 10.1172/JCI69489
– ident: cit0006
  doi: 10.1038/ni.2920
– ident: cit0063
  doi: 10.1007/s00281-016-0600-2
– ident: cit0127
  doi: 10.1038/nri3299
– ident: cit0023
  doi: 10.1093/intimm/dxt039
– ident: cit0150
  doi: 10.1136/gut.2008.163667
– ident: cit0003
  doi: 10.1093/intimm/dxw006
– ident: cit0149
  doi: 10.1136/gut.2007.135053
– ident: cit0112
  doi: 10.1016/j.immuni.2013.07.020
– ident: cit0009
  doi: 10.1016/j.biocel.2012.05.003
– ident: cit0008
  doi: 10.1016/j.immuni.2011.07.010
– ident: cit0075
  doi: 10.1016/j.immuni.2013.01.007
– ident: cit0094
  doi: 10.1016/j.jaci.2015.01.021
– ident: cit0036
  doi: 10.1016/j.jaci.2009.09.054
– ident: cit0055
  doi: 10.4049/jimmunol.0901471
– ident: cit0119
  doi: 10.1111/cea.12787
– ident: cit0035
  doi: 10.4049/jimmunol.178.5.3244
– ident: cit0093
  doi: 10.1165/ajrcmb.19.5.3457
– ident: cit0132
  doi: 10.1126/science.1219328
– ident: cit0097
  doi: 10.1016/j.jaci.2013.09.049
– ident: cit0113
  doi: 10.1155/2014/781649
– volume: 78
  year: 2015
  ident: cit0144
  publication-title: Acta Gastroenterol Belg.
– ident: cit0030
  doi: 10.1111/j.1749-6632.2011.06351.x
– ident: cit0024
  doi: 10.1016/j.cytogfr.2017.07.004
– ident: cit0140
  doi: 10.1016/j.micpath.2013.12.006
– ident: cit0134
  doi: 10.1038/nrgastro.2014.201
– ident: cit0122
  doi: 10.1126/science.1198469
– ident: cit0007
  doi: 10.1038/nri2653
– ident: cit0154
  doi: 10.3892/mmr.2013.1258
– ident: cit0016
  doi: 10.1172/JCI65459
– ident: cit0117
  doi: 10.1007/s12026-014-8540-1
– ident: cit0125
  doi: 10.1016/j.cell.2011.09.025
– ident: cit0084
  doi: 10.1172/JCI65459
– ident: cit0071
  doi: 10.1016/j.it.2013.10.004
– ident: cit0105
  doi: 10.1007/s00281-016-0611-z
– ident: cit0049
  doi: 10.4049/jimmunol.166.7.4391
– ident: cit0038
  doi: 10.1073/pnas.0812530106
– ident: cit0133
  doi: 10.1111/j.1365-2567.2012.03612.x
– ident: cit0138
  doi: 10.1016/j.cyto.2015.10.008
– ident: cit0072
  doi: 10.1136/gutjnl-2013-305947
– ident: cit0077
  doi: 10.1016/j.immuni.2012.01.020
– ident: cit0095
  doi: 10.1002/eji.201242825
– ident: cit0028
  doi: 10.1074/jbc.274.36.25855
– ident: cit0102
  doi: 10.1016/j.jaci.2005.03.011
– ident: cit0153
  doi: 10.1002/ibd.21248
– ident: cit0054
  doi: 10.4049/jimmunol.165.4.1847
– ident: cit0098
  doi: 10.1164/rccm.2105079
– ident: cit0126
  doi: 10.1038/nature11225
– ident: cit0018
  doi: 10.1016/j.cytogfr.2013.09.001
– ident: cit0027
  doi: 10.1128/MCB.16.9.4710
– ident: cit0073
  doi: 10.4049/jimmunol.0900363
– ident: cit0069
  doi: 10.1038/nature07674
– ident: cit0070
  doi: 10.1038/ni1500
– ident: cit0108
  doi: 10.1016/j.jaci.2016.01.055
– ident: cit0029
  doi: 10.1007/BF00204898
– ident: cit0107
  doi: 10.1155/2015/895416
– ident: cit0019
  doi: 10.1016/j.ajpath.2012.03.044
– ident: cit0124
  doi: 10.4049/jimmunol.174.6.3237
– ident: cit0026
  doi: 10.1074/jbc.273.15.9255
– ident: cit0047
  doi: 10.1016/j.immuni.2015.08.020
– ident: cit0088
  doi: 10.1016/j.cytogfr.2016.02.002
– ident: cit0045
  doi: 10.1111/imr.12634
– ident: cit0051
  doi: 10.1016/j.cyto.2004.01.006
– ident: cit0017
  doi: 10.1038/ni.1867
– ident: cit0099
  doi: 10.4049/jimmunol.0801941
– ident: cit0089
  doi: 10.1164/ajrccm.153.4.8616554
– ident: cit0004
  doi: 10.1016/j.coi.2012.02.001
– ident: cit0032
  doi: 10.1016/S0171-2985(11)80414-6
– ident: cit0115
  doi: 10.1038/s41598-017-02422-8
– ident: cit0065
  doi: 10.4049/jimmunol.1303184
– ident: cit0145
  doi: 10.3109/08820139.2015.1122615
– ident: cit0046
  doi: 10.4049/jimmunol.1203420
– ident: cit0114
  doi: 10.1007/s00281-016-0606-9
– ident: cit0022
  doi: 10.4049/jimmunol.1003049
– ident: cit0081
  doi: 10.1038/s41467-017-00674-6
– ident: cit0074
  doi: 10.4049/jimmunol.1301276
– year: 2016
  ident: cit0155
  publication-title: Gut.
– ident: cit0068
  doi: 10.1073/pnas.0809077106
– ident: cit0091
  doi: 10.1165/rcmb.2002-0207OC
– ident: cit0085
  doi: 10.1073/pnas.1301138111
– ident: cit0039
  doi: 10.1038/nri2848
– ident: cit0064
  doi: 10.4049/jimmunol.1502383
– ident: cit0034
  doi: 10.1186/1465-9921-6-33
– ident: cit0080
  doi: 10.1002/eji.201646846
– ident: cit0041
  doi: 10.4049/jimmunol.0901906
– ident: cit0120
  doi: 10.1136/gutjnl-2012-303955
– ident: cit0015
  doi: 10.1111/j.1365-3083.2010.02432.x
– ident: cit0090
  doi: 10.1038/sj.ejhg.5200541
– ident: cit0010
  doi: 10.1038/nri2785
– ident: cit0062
  doi: 10.1002/cyto.a.22348
– ident: cit0101
  doi: 10.1067/mai.2003.1485
– ident: cit0057
  doi: 10.1038/ni.3489
– ident: cit0147
  doi: 10.1016/j.meegid.2018.02.020
– ident: cit0141
  doi: 10.1016/j.micpath.2017.06.040
– ident: cit0013
  doi: 10.1007/978-94-017-9487-9_8
– ident: cit0111
  doi: 10.1111/cea.12787
– volume: 19
  start-page: 5A
  year: 2005
  ident: cit0137
  publication-title: Can J Gastroenterol Hepatol.
SSID ssj0013594
Score 2.2557325
SecondaryResourceType review_article
Snippet T lymphocytes represent an important part of adaptive immune system undertaking different functions to regulate immune responses. CD4+ T cells are the most...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 192
SubjectTerms Cell Differentiation - immunology
Colitis, Ulcerative - immunology
Colitis, Ulcerative - pathology
Colon - immunology
Colon - metabolism
Colon - microbiology
Colon - pathology
Gastrointestinal Microbiome - immunology
Humans
IL-9
Immune Tolerance - immunology
Interferon Regulatory Factors - immunology
Interferon Regulatory Factors - metabolism
Interleukin-4 - immunology
Interleukin-4 - metabolism
Interleukin-9 - immunology
Interleukin-9 - metabolism
Intestinal inflammation
Intestinal Mucosa - immunology
Intestinal Mucosa - metabolism
Intestinal Mucosa - microbiology
Intestinal Mucosa - pathology
Signal Transduction - immunology
Smad Proteins - immunology
Smad Proteins - metabolism
T-Lymphocyte Subsets - immunology
T-Lymphocyte Subsets - metabolism
T-Lymphocytes, Helper-Inducer - immunology
T-Lymphocytes, Helper-Inducer - metabolism
Th9
Transforming Growth Factor beta - immunology
Transforming Growth Factor beta - metabolism
ulcerative colitis
Title Th9 Cells: Probable players in ulcerative colitis pathogenesis
URI https://www.tandfonline.com/doi/abs/10.1080/08830185.2018.1457659
https://www.ncbi.nlm.nih.gov/pubmed/29672174
https://www.proquest.com/docview/2028949428
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BK1AvCMorvGQkbpWjtb221xyQ2pIogqYgSKTcrH0Zh5q4SpxD--uZfSRxRFALFyvaeBJr5_No5_UNQu8kw1mogsIPZch8QiX1aUKkr9KEFYFigTAZ_OF5MhiTT5N4sikbM90lDe-K6519Jf-jVVgDveou2X_Q7PpHYQE-g37hChqG6y11nB2dqqoyZW1f5_Bq6j6oy4rpc7SOZCwroRy1tzCFbgtNpFrWP7SFmy7aJ9Pt0KAjKTWEErqDZCv4_r2sSxs3HdY_G8bXlr1XMTMj-AjuuJhrhJUbmen82sJpoCS7Al-__fU3VkwVINX_DE68mtouovJXvZTtsERATQkraVvSJAIv15I7dtWONWd-LeeLgxlp2dLADsn7w8a7okhKwTbRWFfnUbD34Dc5avEtTu3zL3l_fHaWj3qT0V20H6apTubvH598POlvsk2xGZi5frxVp5fmYN_1N1tnmC2G27_7Kea8MnqIHjhHwzu2qHmE7qjZIbpnR49eHaL7Q1dU8Rh9ABh5BkbvvRWIPAcibzrzNiDyHIi8NoieoHG_Nzod-G6shi-iJGn8SAYxFxgLXHAqqIhxwmWcUCwCpqOKKuQMpyKTBAtFMRWkkJkqMFek0Gn96Cnam9Uz9Rx5rOCcxzyUNJYkKmLOQy5YihOZUZKxoIPIaqNy4Tjn9eiTKg9W1LRuf3O9v7nb3w7qrsUuLenKTQJZWwt5Y6JdhR1Nk0c3yL5dqSwH06rzZWym6uUC7gppRjJw0DvomdXl-nHCLEm1N__iFtIv0cHmDXmF9pr5Ur2Go2zD3zgk_gZpEJoi
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Th9+Cells%3A+Probable+players+in+ulcerative+colitis+pathogenesis&rft.jtitle=International+reviews+of+immunology&rft.au=Shohan%2C+Mojtaba&rft.au=Elahi%2C+Shokrollah&rft.au=Shirzad%2C+Hedayatollah&rft.au=Rafieian-Kopaei%2C+Mahmoud&rft.date=2018-07-04&rft.issn=1563-5244&rft.eissn=1563-5244&rft.volume=37&rft.issue=4&rft.spage=192&rft_id=info:doi/10.1080%2F08830185.2018.1457659&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0883-0185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0883-0185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0883-0185&client=summon